Total Return chart Amplia Therapeutics Limited

Stocks

Delayed Australian S.E. 21:45:53 2026-09-28 EDT			5-day change	1st Jan Change
0.1200 ^AUD	0.00%		-4.00%	-20.00%

09-14	Amplia Therapeutics, ANZGOG Finalize Protocol for Phase Two Ovarian Cancer Trial; Shares Up 4%	MT
08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.